| |
|
|
| |
|
|
| |
Naynesh R. Kamani, MD
|
|
 |
Center of Excellence, Departments, and Programs
The Center for Cancer and Blood Disorders
Blood and Marrow Transplantation
Immunology
Sickle Cell Disease Program
Children’s Research Institute (CRI)
Center for Cancer and Immunology Research
View CRI Profile for Naynesh R. Kamani
Specialties: Allogeneic Blood and Marrow Transplantation, Autologous Blood and Marrow Transplantation, Bone Marrow Harvests, Bone Marrow Failure Syndromes , Primary Immunodeficiency Diseases, Sickle Cell Disease
|
|
| Board Certifications |
American Board of Pediatrics
American Board of Allergy and Immunology
Diagnostic Laboratory Immunology
|
| Foreign Languages |
Amharic, Gujarati |
National Provider Identifier
 |
1528146727 |
|
| Practice Locations |
Children's National Medical Center - Main Hospital
111 Michigan Avenue, NW
Washington, DC
Phone: 202-476-5000
 
|
|
| Biography |
Naynesh R. Kamani, MD, is chair of the Institutional Review Board and medical director of the Office for the Protection of Human Subjects at Children’s National. Prior to taking his current positions, Dr. Kamani was chief of the Division of Blood and Marrow Transplantation and Immunology.
Dr. Kamani is a member of the Board of Directors of the National Marrow Donor Program
(NMDP) and a member of the Executive Committee of the NMDP Board of Directors.
His research interests include hematopoietic cell transplants for non-malignant diseases, primary immune deficiencies, and immune reconstitution.
|
|
| Education |
| Type | School | Location | Degree | Field of Study | Years | | Undergraduate Education | Addis Ababa University | Addis Ababa, Ethiopia | | | 1968 -1970 | | Medical School | Addis Ababa University | Addis Ababa, Ethiopia | Doctor of Medicine | | 1970 -1975 |
|
|
| Training |
| Type | Institution | Location | Position | Specialty | Years | | Residency Program | King's County Hospital | Brooklyn, NY | Resident | Pediatrics | 1979 - 1981 | | Fellowship Program | Children's Hospital of Philadelphia | Philadelphia, PA | Fellow | Pediatric Allergy/Immun & BMT | 1981 - 1983 |
|
|
| Affiliations and Memberships |
| Title | Institution | Committee / Section | Years | | Member | American Society of Hematology | | 2002 - 2009 | | Member | American Society for Blood and Marrow Transplantation | | 1995 - 2009 | | Member | Clinical Immunology Society | | 1988 - 2009 | | Chair | Pediatric Blood and Marrow Transplant Consortium | Non-malignant Diseases Strategy Group | 1997 - 2007 | | Secretary/Treasurer | Pediatric Blood and Marrow Transplant Consortium | | 1999 - 2001 |
|
|
| Research |
| Title | Study Name | Institution | Years | | Investigator | BMT-CTN 0601 Study of Unrelated Donor BMT for children with sickle cell disease- SCURT Trial | National Heart, Lung and Blood Institute | 2008 - 2012 | | | Principal Investigator | Role of Peritransplant immunosuppression on the outcome of stem cell transplantation for the primary immune deficiencies | National Institutes of Health | 2000 - 2006 | | | Read more about the research interests of Naynesh R. Kamani |
|
|
| Publications |
Journal Article, Bray RA, Hurley C, Kamani NR, Woolfrey A, Mueller C, Spellman S, Setterholm M, Confer DL (2008), National Marrow Donor Program HLA matching Guidelines for Unrelated Adult Hematopoietic Cell Transplants, Biology of Blood & Marrow Transplantation, 14, 9 , 44-53.
Journal Article, Perez-Albuerne ED, Eapen M, Klein JP, Gross TG, Lipton JM, Baker KS, Woolfrey AE, Kamani NR (2008), Outcome of unrelated donor stem cell transplantation for children with severe aplastic anemia, British Journal of Haematology, 141, 216-223.
Journal Article, Kamani N, Spellman S, Hurley CK, Barker JN, Smith FO, Oudshoorn M, Bray R, Smith A, Williams TM, Logan B, Eapen M, Anasetti C, Setterholm M, Confer DL (2008), State of the Art Review: HLA matching and Outcome of Unrelated Donor Umbilical Cord Blood Transplants, Biology of Blood & Marrow Transplantation, 14, 1 , 1-6.
Journal Article, Unguru Y, Coppes MJ, Kamani N (2008), Rethinking Pediatric Assent: From requirement to Ideal, Pediatric Clinics of North America, 55, 211-222.
Journal Article, Choi M, Rood B, Kamani N, Lafond D, Packer RJ, Santi MR, MacDonald TJ (2008), Feasibility of Metronomic Maintenance Chemotherapy Following High-Dose Chemotherapy for Malignant Central Nervous System Tumors in Children < 5 Years of Age, Pediatric Blood and Cancer, 50, 970-975.
Journal Article, Rao A, Kamani N, Filipovich A, Lee S, Davies SM, Dalal J, and Shenoy S (2007), Successful bone marrow transplantation for IPEX syndrome following reduced intensity conditioning, Blood, 109, 383-385.
Journal Article, Kollman C, Howe CWS, Anasetti C, Antin JH, Davies SM, Filipovich AH, Hegland J, Kamani N, Kernan NA, King R, Ratanatharathorn V, Weisdorf D, Confer DL (2001), Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age, Blood, 98, 2043-2051.
Journal Article, Kamani, N, Kattamis, A, Carroll, A, Campbell, DC, Bunin, N (2000), Immune reconstitution following autologous purged bone marrow transplantation in children, Journal of Pediatric Hematology/Oncology, 22, 13-19.
Journal Article, Kamani NR, August CS, Bunin N, Bayever E, Leahey A, Goldwein J, Zusman J, Evans AE, D'Angio GJ (1996), A study of thiotepa, etoposide and fractionated total body irradiation as a preparative regimen for bone marrow transplantation in poor prognosis neuroblastoma, Bone Marrow Transplant, 17, 911-916.
Journal Article, Kamani, N.R. (1996), Autotransplants in neuroblastoma, Bone Marrow Transplant, 17, 301-304.
For a more comprehensive list of publications for Naynesh Kamani, MD view the National Library of Medicine’s PubMed online database |
|
|
|
|
|
|
